Official title and information are available only for Plus and Premium subscribers.
Patent Pending Targeted microbubbles are under preclinical development. They retain the same general features as untargeted microbubbles, but they are outfitted with ligands that bind specific receptors expressed by cell types of interest, such as inflamed cells or cancer cells.
To see the additional information details please login and subscribe to a Plus or Premium account.
